OliX PharmaceuticalsInc (226950.KQ) stock: key figures, P/E, revenue and dividend
Energy · Coal & Consumable Fuels · South Korea · ISIN KR7226950004
OliX PharmaceuticalsInc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 5.68 bn KRW | 14.67 bn KRW |
| Gross profit | 5.68 bn KRW | 14.67 bn KRW |
| Operating income | -38.61 bn KRW | -29.97 bn KRW |
| EBIT | -36.41 bn KRW | -11.43 bn KRW |
| Net income | -40.66 bn KRW | -15.74 bn KRW |
| Diluted EPS – continuing operations | -2,202.58 KRW | -775.48 KRW |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About OliX PharmaceuticalsInc
OliX Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing RNA interference (RNAi) therapeutics for dermal, ophthalmic, and pulmonary diseases. The company's products pipeline includes OLX101A for skin scar; OLX104C for androgenic alopecia; OLX301A for age-related macular degeneration; OLX702A for metabolic dysfunction-associated steatohepatitis; OLX703A for hepatitis; and OLX301D for subretinal fibrosis. The company has a license and collaboration agreement with Hansoh Pharmaceuticals; development collaboration with Korea Institute of Technology; and research collaboration with the University of Virginia. The company was formerly known as Biomolecular Therapeutics Inc. OliX Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Suwon-si, South Korea.
More stocks
- Arendals Fossekompani ASA (AFK.OL)
- Amerant Bancorp Inc. (AMTB)
- TotalEnergies EP Gabon (EC.PA)
- Wangneng Environment Co Ltd (002034.SZ)
- PowerX Inc (485A.T)
- Lampsa Hellenic Hotels SA (LAMPS.AT)
- Browave (3163.TWO)
- Instalco AB (INSTAL.ST)
- Ladder Capital Corp (LADR)
- Jiangsu Zeyu Intelligent Power Co.Ltd. (301179.SZ)
- Sunwave Communications Co Ltd (002115.SZ)
- Vor Biopharma Inc. (VOR)
Not investment advice. All data without warranty, price as of 06.11.2026. Details in the risk notice.